cd38 inhibitor and 5-amino-1mq combination benefits A Potent BCMA/CD38 Dual-Targeting Immunotherapy Leads a New Paradigm in Second-Line MM Treatment—MAJEStec-3 Study Heavily Released Bioregulators CD38 as theranostic target Size:1000 mcg/ml - 30 ml x 5
SKU: 40944003596
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22